Performance and Safety of I-020805 in Prevention of Cerebrospinal Fluid (CSF) Leakage Following Elective Craniotomy
NCT ID: NCT01295619
Last Updated: 2016-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2011-02-28
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I-020805 was delivered from a double syringe applicator that creates a fine layer over the dura. This layer quickly sets within seconds to form a watertight seal.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
I-020805
This was a prospective, open, multi-center, single-arm study to investigate I-020805 in patients following elective cranial surgery. If they met the inclusion/ exclusion criteria, they receive I-020805 after suturing of the dura. If necessary, autologous grafts were to be used to augment dural closure.
I-020805
A thin layer of I-020805 applied up to two times on the sutured dura mater
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
I-020805
A thin layer of I-020805 applied up to two times on the sutured dura mater
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female of 18 years old or over
* Elective cranial procedure entailing a dural incision of at least 2 cm in length
* Requires a procedure involving surgical wound classification Class I/Clean
* Signed informed consent form
* Negative pregnancy test at screening for women of childbearing potential and agreeing to use an acceptable birth control method or abstinence until 90 days post-surgery
Intra-operative
* Surgical wound classification Class I/Clean
* Dural margin from bony edges of at least 3 mm throughout
* Spontaneous expression of CSF assessed visually or a CSF leakage upon Valsalva maneuver
Exclusion Criteria
* Cranial procedure requiring translabyrinthine, transoral and/or any procedure penetrating the air sinus or mastoid air cells
* Presence of symptomatic hydrocephalus
* Pre-existing external ventricular drainage or lumbar CSF drain
* Radiotherapy in the planned surgical region which ended within 3 months prior to planned surgery
* Presence of systemic infection
* Known history of hemophilia or other clinically significant coagulopathy
* Known oral anticoagulant use
* Pregnancy or breast feeding
* Known allergy to any components of I-020805
* Previous participation in this trial or any investigational drug or device study within 30 day of screening
* Known clinically significant organ or systemic diseases
* Known or suspected non-compliance with trial procedures
Intra-operative
* Patient not meeting the pre-operative eligibility criteria
* Not able to tolerate a Valsalva maneuver
* Gap of more than 2 mm remaining after primary closure of dura
* Use of synthetic or non-autologous duraplasty material
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kuros Biosurgery AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Virginia Jamieson, MD
Role: STUDY_DIRECTOR
Kuros Biosurgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charite Universitätsmedizin (01)
Berlin, , Germany
Orszagos Idegtudomanyi Intezet (11)
Budapest, , Hungary
Debreceni Tudomanyegyetem (12)
Debrecen, , Hungary
Szegedi Tudomanyegyetem (10)
Szeged, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CS I-020805/01
Identifier Type: -
Identifier Source: org_study_id